Estimation and Correlation of Clinical Significance of Lipoprotein (a) as a Risk Factor of Atherosclerotic Vascular Events in Elderly: A 1-year Cross-sectional Study in KLE’s Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi

Introduction: Lipoprotein (a) (Lp(a)) was identified as a variant of low-density lipoprotein (LDL) 40 years ago. Lp(a) consists of one LDL particle containing apoB-100 and one molecule of a large, highly polymorphic glycoprotein known as apo (a). The study aimed to evaluate and correlate the clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: Yashoda Tushar Maladkar, Veerappa Annasaheb Kothiwale
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Journal of the Scientific Society
Subjects:
Online Access:https://journals.lww.com/10.4103/jss.jss_183_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556595124731904
author Yashoda Tushar Maladkar
Veerappa Annasaheb Kothiwale
author_facet Yashoda Tushar Maladkar
Veerappa Annasaheb Kothiwale
author_sort Yashoda Tushar Maladkar
collection DOAJ
description Introduction: Lipoprotein (a) (Lp(a)) was identified as a variant of low-density lipoprotein (LDL) 40 years ago. Lp(a) consists of one LDL particle containing apoB-100 and one molecule of a large, highly polymorphic glycoprotein known as apo (a). The study aimed to evaluate and correlate the clinical significance of Lp(a) as a risk factor for atherosclerotic vascular events in the elderly population. Materials and Methods: This cross-sectional study was conducted among patients admitted in a tertiary care hospital for for 1 year. One hundred and forty-two study participants included in the study were divided into two groups atherosclerotic vascular event group (2 subgroups: Cardiovascular atherosclerotic vascular event subgroup and neurological atherosclerotic vascular event subgroup) and no atherosclerotic vascular event group. Detailed history, examination, and parameters such as serum Lp(a), serum high-density lipoproteins, LDL, total cholesterol, triglycerides, glycated hemoglobin, and creatinine were tested. Results: Among 142 study participants in the study, majority of study participants were male (n = 96, 67.6%). The mean age was 71.63 years. High Lp(a) levels were noted in 51.41% of study participants. High Lp(a) levels were seen in 56% of study participants in the cardiovascular atherosclerotic vascular event subgroup, 43.33% of study participants in the neurological atherosclerotic vascular event subgroup and 51.61% in no atherosclerotic vascular event group. Conclusion: Our study concludes that Lp(a) may not be used to infer any clinical significance, nor may it have any role to play as a risk factor for atherosclerotic vascular events in the elderly (age >65 years).
format Article
id doaj-art-ba04283f47254325902826e1f850a971
institution Kabale University
issn 0974-5009
2278-7127
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of the Scientific Society
spelling doaj-art-ba04283f47254325902826e1f850a9712025-01-07T07:23:01ZengWolters Kluwer Medknow PublicationsJournal of the Scientific Society0974-50092278-71272024-12-0151455956510.4103/jss.jss_183_24Estimation and Correlation of Clinical Significance of Lipoprotein (a) as a Risk Factor of Atherosclerotic Vascular Events in Elderly: A 1-year Cross-sectional Study in KLE’s Dr. Prabhakar Kore Hospital and Medical Research Centre, BelagaviYashoda Tushar MaladkarVeerappa Annasaheb KothiwaleIntroduction: Lipoprotein (a) (Lp(a)) was identified as a variant of low-density lipoprotein (LDL) 40 years ago. Lp(a) consists of one LDL particle containing apoB-100 and one molecule of a large, highly polymorphic glycoprotein known as apo (a). The study aimed to evaluate and correlate the clinical significance of Lp(a) as a risk factor for atherosclerotic vascular events in the elderly population. Materials and Methods: This cross-sectional study was conducted among patients admitted in a tertiary care hospital for for 1 year. One hundred and forty-two study participants included in the study were divided into two groups atherosclerotic vascular event group (2 subgroups: Cardiovascular atherosclerotic vascular event subgroup and neurological atherosclerotic vascular event subgroup) and no atherosclerotic vascular event group. Detailed history, examination, and parameters such as serum Lp(a), serum high-density lipoproteins, LDL, total cholesterol, triglycerides, glycated hemoglobin, and creatinine were tested. Results: Among 142 study participants in the study, majority of study participants were male (n = 96, 67.6%). The mean age was 71.63 years. High Lp(a) levels were noted in 51.41% of study participants. High Lp(a) levels were seen in 56% of study participants in the cardiovascular atherosclerotic vascular event subgroup, 43.33% of study participants in the neurological atherosclerotic vascular event subgroup and 51.61% in no atherosclerotic vascular event group. Conclusion: Our study concludes that Lp(a) may not be used to infer any clinical significance, nor may it have any role to play as a risk factor for atherosclerotic vascular events in the elderly (age >65 years).https://journals.lww.com/10.4103/jss.jss_183_24cardiovascular atherosclerotic vascular eventlipid profilelipoprotein (a)neurological atherosclerotic vascular event
spellingShingle Yashoda Tushar Maladkar
Veerappa Annasaheb Kothiwale
Estimation and Correlation of Clinical Significance of Lipoprotein (a) as a Risk Factor of Atherosclerotic Vascular Events in Elderly: A 1-year Cross-sectional Study in KLE’s Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi
Journal of the Scientific Society
cardiovascular atherosclerotic vascular event
lipid profile
lipoprotein (a)
neurological atherosclerotic vascular event
title Estimation and Correlation of Clinical Significance of Lipoprotein (a) as a Risk Factor of Atherosclerotic Vascular Events in Elderly: A 1-year Cross-sectional Study in KLE’s Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi
title_full Estimation and Correlation of Clinical Significance of Lipoprotein (a) as a Risk Factor of Atherosclerotic Vascular Events in Elderly: A 1-year Cross-sectional Study in KLE’s Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi
title_fullStr Estimation and Correlation of Clinical Significance of Lipoprotein (a) as a Risk Factor of Atherosclerotic Vascular Events in Elderly: A 1-year Cross-sectional Study in KLE’s Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi
title_full_unstemmed Estimation and Correlation of Clinical Significance of Lipoprotein (a) as a Risk Factor of Atherosclerotic Vascular Events in Elderly: A 1-year Cross-sectional Study in KLE’s Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi
title_short Estimation and Correlation of Clinical Significance of Lipoprotein (a) as a Risk Factor of Atherosclerotic Vascular Events in Elderly: A 1-year Cross-sectional Study in KLE’s Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi
title_sort estimation and correlation of clinical significance of lipoprotein a as a risk factor of atherosclerotic vascular events in elderly a 1 year cross sectional study in kle s dr prabhakar kore hospital and medical research centre belagavi
topic cardiovascular atherosclerotic vascular event
lipid profile
lipoprotein (a)
neurological atherosclerotic vascular event
url https://journals.lww.com/10.4103/jss.jss_183_24
work_keys_str_mv AT yashodatusharmaladkar estimationandcorrelationofclinicalsignificanceoflipoproteinaasariskfactorofatheroscleroticvasculareventsinelderlya1yearcrosssectionalstudyinklesdrprabhakarkorehospitalandmedicalresearchcentrebelagavi
AT veerappaannasahebkothiwale estimationandcorrelationofclinicalsignificanceoflipoproteinaasariskfactorofatheroscleroticvasculareventsinelderlya1yearcrosssectionalstudyinklesdrprabhakarkorehospitalandmedicalresearchcentrebelagavi